5 years ago
Prostate Cancer Prediction Looks to Machine Learning for Accuracy Boost
Diagnosing prostate cancer (PCa) has continually faced hurdles that have been difficult to overcome. The current diagnostic standard, the prostate-specific antigen or PSA test, has many limitations—as Richard J. Ablin, PhD, discoverer of PSA in 1970, has vociferously argued on countless occasions. Yet, with such limited diagnostic options and the speed at which PCa can metastasize and become deadly, the devil you know is better than the devil you don’t.
Continue Reading
https://www.genengnews.com
Join the Discussion